â‚©
9450.00
Jan 3
Business Description
Daesung Microbiological Labs Co Ltd
SIC : 111
ISIN : KR7036480002
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 38.28 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.07 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1 | |||||
3-Year EBITDA Growth Rate | -8.5 | |||||
3-Year FCF Growth Rate | 39.4 | |||||
3-Year Book Growth Rate | 0.9 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.38 | |||||
9-Day RSI | 54.46 | |||||
14-Day RSI | 51.45 | |||||
6-1 Month Momentum % | -9.46 | |||||
12-1 Month Momentum % | -11.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.62 | |||||
Quick Ratio | 1.94 | |||||
Cash Ratio | 1.34 | |||||
Days Inventory | 216.04 | |||||
Days Sales Outstanding | 57.35 | |||||
Days Payable | 24.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.79 | |||||
3-Year Dividend Growth Rate | -4.1 | |||||
5-Year Yield-on-Cost % | 0.67 | |||||
Shareholder Yield % | 2.69 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.45 | |||||
Operating Margin % | -10.03 | |||||
Net Margin % | -11.59 | |||||
FCF Margin % | 1.99 | |||||
ROE % | -7.69 | |||||
ROA % | -4.51 | |||||
ROIC % | -4.48 | |||||
ROC (Joel Greenblatt) % | -4.98 | |||||
ROCE % | -4.29 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.48 | |||||
PB Ratio | 1.04 | |||||
Price-to-Tangible-Book | 1.06 | |||||
Price-to-Free-Cash-Flow | 75.13 | |||||
Price-to-Operating-Cash-Flow | 23.08 | |||||
EV-to-EBIT | -21.62 | |||||
EV-to-EBITDA | 83.6 | |||||
EV-to-Revenue | 2.03 | |||||
EV-to-FCF | 99.06 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Earnings Yield (Greenblatt) % | -4.62 | |||||
FCF Yield % | 1.33 | |||||
Forward Rate of Return (Yacktman) % | -35.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Daesung Microbiological Labs Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 24,164.119 | ||
EPS (TTM) (â‚©) | -736 | ||
Beta | 0.81 | ||
Volatility % | 8.5 | ||
14-Day RSI | 51.45 | ||
14-Day ATR (â‚©) | 343.452611 | ||
20-Day SMA (â‚©) | 9324.5 | ||
12-1 Month Momentum % | -11.08 | ||
52-Week Range (â‚©) | 8460 - 12690 | ||
Shares Outstanding (Mil) | 3.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Daesung Microbiological Labs Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Daesung Microbiological Labs Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Daesung Microbiological Labs Co Ltd Frequently Asked Questions
What is Daesung Microbiological Labs Co Ltd(XKRX:036480)'s stock price today?
When is next earnings date of Daesung Microbiological Labs Co Ltd(XKRX:036480)?
Does Daesung Microbiological Labs Co Ltd(XKRX:036480) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |